StockViz
RANKINGS
Cabaletta Bio, Inc.
NasdaqGS:CABA
Sector
Industries
Location
Market Cap
USD 152.00 M
Share Price
USD 1.69
Avg Daily Volume
2,077,588
Change (1 day)
3.68%
Change (1 year)
-78.50%
Change (YTD)
-25.55%
Cabaletta Bio, Inc. Key Metrics 2018 - 2025
This table shows the Key Metrics for Cabaletta Bio, Inc. going from 2018 until 2025. Key metrics are specific quantitative measures used to assess the performance and progress of a company, often tailored to its industry and objectives, providing insights into growth, profitability, and operational efficiency.
Key Metrics
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
AbbVie Inc.
USD 190.58
ABBV
+4.19
2.25%
Novo Nordisk A/S
USD 67.42
NOVO-B.CO
+0.26
0.39%
Roche Holding AG
USD 338.90
RO.SW
+1.87
0.56%
Novartis AG
USD 118.69
NOVN.SW
-0.95
-0.80%
Abbott Laboratories
USD 131.74
ABT
+0.25
0.19%
AstraZeneca PLC
USD 140.04
AZN.L
-0.39
-0.28%
Merck & Co., Inc.
USD 82.43
MRK
+0.91
1.12%
Thermo Fisher Scientific Inc.
USD 416.31
TMO
-1.68
-0.40%
Amgen Inc.
USD 299.02
AMGN
+6.51
2.23%
Boston Scientific Corporation
USD 103.19
BSX
-0.29
-0.28%
Pfizer Inc.
USD 24.61
PFE
0.00%
Gilead Sciences, Inc.
USD 109.85
GILD
+0.79
0.72%
Vertex Pharmaceuticals Incorporated
USD 469.55
VRTX
+5.35
1.15%
Sanofi
USD 96.84
SAN.PA
+0.90
0.94%
Bristol-Myers Squibb Company
USD 47.17
BMY
+0.74
1.59%
CSL Limited
USD 160.99
CSL.AX
-0.54
-0.33%
GSK plc
USD 19.08
GSK.L
+0.31
1.65%
Chugai Pharmaceutical Co., Ltd.
USD 46.49
4519.T
+0.50
1.10%
Siemens Healthineers AG
USD 53.67
SHL.DE
+0.10
0.18%
Regeneron Pharmaceuticals, Inc.
USD 547.93
REGN
-0.03
-0.01%